Drugs / QIVc
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03932682 | May 2019 → Nov 2023 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QIVc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03932682 ↗ |
| Modality | Vaccine | “cell culture-derived quadrivalent inactivated influenza vaccine (QIVc)” PMID 41962984 ↗ May 2026 |